Every Form 4 that RADNOSTIX INC (INIS) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow INIS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full INIS filings page.
RADNOSTIX INC director and 10% owner Christopher G. Grosso, through Kershner, Grosso & Co., purchased a $500,000 convertible promissory note from the company. The note bears simple interest at 5% per year, with interest payable annually and optional paid-in-kind interest for the first two years.
The lender may convert principal and accrued interest into common stock at $0.07 per share, initially corresponding to 7,142,857 shares based on principal alone, subject to anti-dilution adjustments. RADNOSTIX can force conversion if the volume weighted-average closing price exceeds $0.12 per share over thirty consecutive trading days, and the instrument carries an expiration date of June 30, 2031.
RADNOSTIX INC director and 10% owner Christopher G. Grosso reported non-market restructuring transactions involving 581,536 shares of Common Stock. These entries reflect shares issued in lieu of cash dividends on the company’s Series C Redeemable Convertible Preferred Stock, at the holder’s option, rather than open-market buying or selling.
The shares were allocated across several indirect accounts, including a credit shelter trust and UTMA custodial accounts for his children, as well as his direct holdings. After these stock-dividend issuances, his reported direct Common Stock position was 38,477,083 shares, with additional indirect holdings in the related accounts.